Bio-Rad Laboratories, Inc. Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.

BIO

Kedudukan dalam Saham #2169
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Harga Saham
$352.07
Modal Pasaran
$9.41B
Perubahan (1 hari)
-0.23%
Perubahan (1 tahun)
13.56%
Negara
US
Perdagangan Bio-Rad Laboratories, Inc. (BIO)

Kategori

Healthcare
Pendapatan untuk Bio-Rad Laboratories, Inc. (BIO)
Pendapatan pada Jun 2026 TTM: $350.40M
Menurut laporan kewangan terkini Bio-Rad Laboratories, Inc., pendapatan semasa syarikat ialah $350.40M. Pada tahun 2024, syarikat memperoleh pendapatan sebanyak $-2.34B, penurunan berbanding pendapatan pada tahun 2023 yang berjumlah $-850.10M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Bio-Rad Laboratories, Inc. dari 2000 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $350.40M -64.80%
2025 $995.50M -142.50%
2024 $-2.34B 175.55%
2023 $-850.10M -81.93%
2022 $-4.70B -186.33%
2021 $5.45B 10.80%
2020 $4.92B 117.51%
2019 $2.26B 345.66%
2018 $507.36M 418.75%
2017 $97.81M 135.33%
2016 $41.56M -71.50%
2015 $145.85M 10.86%
2014 $131.56M 17.06%
2013 $112.39M -51.47%
2012 $231.58M -1.77%
2011 $235.76M 7.03%
2010 $220.28M 18.54%
2009 $185.83M 30.10%
2008 $142.84M 18.21%
2007 $120.84M -14.92%
2006 $142.03M 52.11%
2005 $93.37M -4.06%
2004 $97.33M -14.39%
2003 $113.69M 8.89%
2002 $104.41M 60.70%
2001 $64.97M 42.97%
2000 $45.44M 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$7.51B 2,043.55%
US
$5.56B 1,487.61%
IE
$5.15B 1,369.18%
US
$3.86B 1,001.88%
US
- -
DE